Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (WA 1706/8-1, WA 1706/12-1)
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Aachen, Medizinische Fakultät (O3-3)
Deutsche Krebshilfe (TRACK-AML)
Bundesministerium für Bildung und Forschung (VIP+ Epi-Blood-Count)
Else Kröner-Fresenius-Stiftung (ForTra gGmbH für Forschungstransfer)
RWTH Aachen University
Received: 25 February 2022
Accepted: 7 June 2022
First Online: 15 June 2022
: Mesenchymal stromal cells and KIT+ cells were taken after informed and written consent and the study was approved by the Ethic Committee of the Use of Human Subjects at the University of Aachen (permit numbers: EK128/09 and EK206/09, respectively).
: Not applicable.
: W.W. and P.G. are involved in Cygenia GmbH that can provide service for various epigenetic signatures, including Epi-Pluri-Score analysis (ExternalRef removed). Apart from this, the authors declare no competing interests.